Rep. Katie Porter @RepKatiePorter
Just 3 companies control nearly all of our insulin supply: Eli Lilly, Sanofi, and Novo Nordisk. Shocker: it turns out they raise prices in tandem—at least 13x in 10 years—while patients are rationing or starving themselves to try to cut costs. I want answers. https://t.co/AtkH3OonTs — PolitiTweet.org